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Purpose: The mechanism of venous pressure decrease during exercise still remains unclear. To explore the components
involved with the regulation of ambulatory venous pressure, we reinvestigated the pattern of pressure decrease during
tiptoe exercise with a newly developed mathematic model.
Methods: Seventeen healthy limbs of 16 volunteers (normal group) and 35 limbs of 33 patients with signs and symptoms
of chronic venous insufficiency were studied. Seventeen limbs had superficial venous incompetence (SVI), and 18 showed
deep venous incompetence with or without concomitant superficial venous reflux. All subjects were examined with
ambulatory venous pressure measurements. As parameters obtained from serial phasic changes in pressure during tiptoe
movements, the pressure reduction fraction per step (decreasing component) and the pressure increase per step
(increasing component) were calculated with application of the mathematic hemodynamic model and assessed compar-
atively in the three groups with different types of reflux (normal, SVI, and deep venous incompetence group).
Results: The pressure increase per step was significantly different in each of the three groups (P < .0001, with analysis of
variance), whereas no apparent difference was seen in the mean pressure reduction fraction per step among the groups.
With addition of the inflation of ankle cuff, the value of pressure increase in limbs with SVI was significantly reduced (P
.0004, with Wilcoxon signed rank test), although no changes were seen in the pressure reduction fraction in each group.
Conclusion: Our results indicate that the pressure reduction fraction, representing calf muscle pump function, is
independent of the existence or site of valve incompetence. On the other hand, the pressure increase, corresponding to the
degree of reflux during exercise, correlates strongly with the severity of venous insufficiency. The theoretic model can
separate the two components responsible for ambulatory venous pressure changes, calf muscle pump function and venous
reflux, and provide better understanding of venous hemodynamics. (J Vasc Surg 2002;36:137-42.)
Ambulatory venous hypertension, resulting from ve-
nous outflow obstruction, valvular incompetence, or their
combination, is the fundamental abnormality in chronic
venous insufficiency (CVI). Ambulatory venous pressure
(AVP) has been and continues to be the simplest and most
direct measurement of venous hypertension and is gener-
ally considered the gold standard for assessment of the basic
hemodynamic derangement present in patients with CVI.1
Although AVP measurements can quantitate the overall
effect of all hemodynamic factors involved in venous insuf-
ficiency, AVP is not able to provide any information with
reference to each individual component, calf muscle pump
ejection and the degree of venous reflux, that contributes to
the venous problem.
The actual changes in pressure obtained from the foot
venous pressure measurements show several constituents:
1, lowest pressure achieved at the end of the tiptoe exercise
(AVP); 2, recovery process after exercise (recovery time);
and 3, pattern of pressure decrease during exercise. Among
these components, the AVP and the recovery time have
been well documented, and numerous authors have inves-
tigated their usefulness in patient assessment.2-12 However,
the process of serial phasic changes in pressure during
exercise has been a subject of little research so far, mainly
because of a lack of appropriate methods of analysis. To
obtain a better understanding of venous hemodynamics,
we developed a mathematic hemodynamic model of the
venous pressure variation during tiptoeing. The aim of our
study was to determine the validity of the newly developed
mathematic model and its value in the assessment of CVI.
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METHODS
Patients. The data of AVP measurements, obtained
from 35 limbs of 33 patients with signs and symptoms of
CVI and 17 healthy limbs of 16 volunteers with no history
of venous thrombosis or venous surgery and no evidence of
clinical venous disease, were included in the study. All
patients underwent investigation with duplex ultrasonog-
raphy13 and ascending phlebography14 with standardized
technique. On the basis of duplex scan and phlebographic
examination, the limbs were classified as having superficial
venous insufficiency (SVI) only or deep venous insuffi-
ciency (DVI) with or without concomitant SVI. Patients
with chronic venous obstruction shown on ascending phle-
bography were excluded because the aim of this study was
to assess the effect of venous reflux without interference
from other causes of venous hypertension. No patients had
ischemic symptoms associated with arterial disease, and all
had an ankle brachial pressure index greater than or equal
to 1.0. The healthy volunteers underwent assessment clin-
ically and with ultrasound scan to exclude asymptomatic
venous reflux at the saphenofemoral and saphenopopliteal
junction and at the femoral and popliteal veins. All mea-
surements were made after informed consent was obtained
from the participants. All limbs were divided into three
groups (normal, SVI, and DVI). This major division was
made on the basis of the presence or absence of venous
reflux and the extent of valvular incompetence. According
to these laboratory findings, the following distribution was
provided: normal group, 17 limbs; SVI group, 17 limbs;
and DVI group, 18 limbs.
Ambulatory venous pressure measurements. Pres-
sures in a dorsal vein of the foot were recorded with the
patients standing still, followed by a standard exercise of 10
tiptoe movements at the rate of one per second. The details
of this technique have been described previously.15 The
exercise was repeated after inflation of a 2.5 cmwide
pneumatic cuff at the ankle to a pressure of 80 mm Hg to
occlude the superficial veins. Each bout of exercise was
repeated three times, without and with the application of
the ankle cuff. The AVP was determined as the lowest
pressure achieved at the end of the serial tiptoe exercise (Fig
1) Normalization of the AVP after inflation of the pneu-
matic cuff indicated a normal deep venous system.
Mathematic hemodynamic model. The theoretic
model was constructed on the basis of the following as-
sumptions: 1, because the decrease of venous pressure
during tiptoe movements appeared to be exponential, the
proportion of pressure decrease (pressure reduction frac-
tion x) with every step was assumed to be constant; and 2,
the pressure increase (I) as a result of the arterial inflow and
the venous reflux if present was considered to be constant
for each tiptoe cycle. The process of developing this model
is detailed in the Appendix (online only). Briefly, the pres-
sure at the end of the first tiptoe cycle P1 can be expressed
as follows: P1  P0  x P0  I, where P0 is the resting
pressure when the patient is standing still, x is the pressure
reduction fraction at each step, and I is the constant pres-
sure increase per step. Similarly, at the end of nth tiptoe
cycle, the following equation can be derived: Pn Pn  1
x Pn 1 I, which can be transformed to: Pn (1 x) Pn
1 I.
When a is substituted for (1 x), the previous equation
becomes: (1) Pn a Pn 1 I. Pn can be expressed in terms
of a, P0, and I as: (2) Pn  a
n P0  (1  a
n) I / (1  a)
(Appendix, online only).
Considering the asymptotic phase (ie, steady state
phase that occurs after five to seven tiptoe movements when
the pressure reduction per step is equal to I) and taking
logarithms, the following equation can be obtained (Ap-
pendix, online only): (5) log10 (Pn  P)  n log10 a 
log10 (P0 P). This is of the form YmX c, and with
plotting log10 (Pn P) against n for an individual patient,
log10 a would be the slope and log10 (P0  P) the
intercept (Fig 2).
Fig 1. AVP tracing during 10 tiptoe movements and recovery
phase. P1, Pressure at end of first tiptoe cycle; P2, pressure at end of
second tiptoe cycle; P3, pressure at end of third tiptoe cycle.
Fig 2. Scatter plot and regression of log10 (Pn  P) against
corresponding number of steps in one limb.
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Thus, the slope (log10 a) and therefore x, that is, the
pressure reduction fraction per step, can be calculated from
a plot with the value of log10 (Pn P) on the Y axis and the
corresponding number of steps on the X axis. At the steady
state, I, which is the same as pressure increase at each step,
can also be calculated by substituting a in equation 3
(Appendix, online only), which becomes as follows: I P
(1  a)  x P.
In this study, the significance of the two parameters, I
representing the pressure increase as a result of reflux and x
representing the pressure reduction fraction per step, ob-
tained from the application of the mathematic model to the
clinical venous pressure measurements, was investigated in
the three groups of limbs studied. In addition, as the
traditional indicator of venous hypertension, the AVP also
was studied in terms of the relationship to these novel
parameters.
Statistical analysis. The linear regression analysis was
used to verify the accuracy of the theoretic model. Statisti-
cal significance among different groups was assessed with
one-way analysis of variance with post hoc testing with
Scheffe´ F test. Wilcoxon signed rank test for paired samples
was adopted where appropriate. The correlations between
parameters were calculated with Pearson correlation coef-
ficient method.
RESULTS
When the value of log10 (Pn  P) was plotted against
the number of steps for each patient, the points were always
close to a straight line in all patients (r2 0.9; P .001, in
all limbs), which confirmed the validity of the model.
Examples of three individual legs (normal, SVI, and DVI)
are shown in Fig 3.
The results of the hemodynamic parameters obtained
from AVP measurements were stratified according to the
extent of reflux and are summarized in Table I. Analysis of
variance comparisons among the three groups revealed
significant differences in the mean values of AVP and I (P
.0001), whereas no difference was seen in the value of x
among groups (P .14). In comparison of each of the two
groups, the AVP and I showed statistically significant dif-
ferences between all two categories of limbs with different
types of reflux. On the other hand, the x measurements
showed no apparent differences between any categories.
With respect to the effects of applying an ankle cuff, the
changes in each parameter, divided into three groups, also
are shown in Table II. The cuff inflation at the ankle level
did not affect the results of all parameters in both the
normal and the DVI groups. On the contrary, in the SVI
group, the values of all parameters except for the x im-
proved significantly after the reflux in the superficial veins
was abolished with use of the ankle cuff (P .003 for AVP;
and P  .0004 for I, with Wilcoxon signed rank test).
Correlations between the new derived parameters (I
and x) and the AVP are depicted in Fig 4. A significant
correlation was recognized between I and AVP (r  .81;
P  .0001; Fig 4 , A), although x revealed no apparent
correlation with AVP (r  .05; Fig 4 , B).
Fig 3. Raw data from venous pressure measurements and corresponding linear regression analyses in three limbs.
Sample A (normal limb): P  16 mm Hg, and slope (log10 a)  0.39. Then, a  0.404, x  0.596, and I  x P
 9.5 mm Hg. Sample B (limb with SVI): P 37 mm Hg, and slope (log10 a)0.253. Then, a 0.558, x 0.442,
and I x P  16.3 mm Hg. Sample C (limb with DVI): P  65 mm Hg, and slope (log10 a)0.241. Then, a
0.574, x  0.426, and I  x P  27.7 mm Hg.
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DISCUSSION
AVP measurement is traditionally considered to be the
gold standard in evaluation of venous function of the lower
limb. Historically, the first measurement of venous pressure
with direct cannulation of a vein in the foot was performed
in 1925 by Barber and Shatara,16 who found that the
standing pressure corresponded to the hydrostatic pressure
from the level of the heart to the point of measurement. In
1949, Pollack and Wood17 showed that the venous pres-
sure in the foot was reduced during exercise, probably
because of the emptying of leg veins by calf muscle pump.
Since then, venous pressure measurements have been ac-
cepted as the main objective method to assess venous
hypertension or overall venous physiology, including calf
muscle pump function, in spite of its inherently invasive
nature.
With focus on the pressure changes in actual venous
pressure measurements, two components construct the
waveform of the pressure changes during exercise, that is,
the decreasing component reflecting the efficacy of calf
muscle pump and the increasing component resulting from
venous reflux and arterial inflow. The AVP, the lowest
pressure achieved after exercise, is the most frequently used
parameter in venous pressure studies and is thought to be
Table I. AVP, pressure reduction fraction per step, and pressure increase per step without ankle cuff for three groups,
categorized according to anatomic extent of reflux
Normal (n  17) SVI (n  17) DVI (n  18) ANOVA
AVP 31.4  11.5 46.3  14.9* 74.8  13.0† P  .0001
x 49.3  10.0 56.3  12.7 50.1  11.1 P  .14
I 8.8  3.2 15.5  5.0‡ 25.4  6.1§ P  .0001
Values are mean  standard deviation.
*Normal versus SVI, P  .008.
†SVI versus DVI, P  .0001, with Scheffe´ F test.
‡Normal versus SVI, P  .003.
§SVI versus DVI, P  .0001, with Scheffe´ F test.
ANOVA, Analysis of variance.
Table II. AVP, pressure reduction fraction per step, and pressure increase per step with ankle cuff for three groups,
categorized according to anatomic extent of reflux
Normal (n  17) SVI (n  17) DVI (n  18) ANOVA
AVP 31.7  13.5 32.9  18.8 71.3  9.9* P  .0001
x 46.3  11.4 47.2  13.7 50.6  15.3 P  .67
I 8.4  2.7 8.3  4.0 22.9  7.5† P  .0001
Values are mean  standard deviation.
*Normal versus DVI, P  .0001; SVI versus DVI, P  .0001, with Scheffe´ F test.
†Normal versus DVI, P  .0001; SVI versus DVI, P  .0001; with Scheffe´ F test.
ANOVA, Analysis of variance.
Fig 4. A, Correlation of I with AVP for all subjects (r  0.81; P  .0001, with Pearson correlation coefficient
method). B, Correlation of x with AVP for all subjects (r  0.05, with Pearson correlation coefficient method).
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the combined product of these two components. In fact,
considerable differences in the pattern of pressure decrease
are observed when patients perform tiptoe exercise, which
may be physiologically more meaningful. Some patients
achieve the lowest venous pressure easily in the early phase
of exercise, and others need more steps to decrease their
pressures. Until recently, no research had been made to
elucidate these dynamic changes in venous pressure during
exercise, because of the lack of appropriate methods in
analyzing this process. Therefore, we attempted to investi-
gate the two components (effect of ejection and effect of
reflux) mentioned previously in patients with CVI as the
result of valve incompetence.
The mathematic model used in this study is particularly
useful in separating the two components and appreciating
the distinct pattern of the pressure changes induced by
exercise. The strong correlation between the logarithm of
pressure decrease and the number of steps observed in all
measurements constitutes evidence of the validity of this
model. As a consequence, our model provided two unique
parameters (I and x) that reflect the effect of venous reflux
and calf muscle pump function, respectively, during tiptoe
exercise. Application of this model to clinical settings en-
ables us to assess venous hemodynamics during exercise
and will shed light on “ambulatory” venous physiology in
terms of venous pressure changes, which was previously
poorly defined.
In this study, we intended to elucidate the correlation
between the extent of reflux and the newly derived param-
eters obtained from the model. As a result, we found that
the I provided statistical differentiation among groups of
normal limbs, limbs with SVI, and limbs with DVI, as well
as the AVP could. I showed trends indicative of progressive
worsening of venous hemodynamics as the venous reflux
occurred and extended from superficial to deep venous
system. On the other hand, x studies revealed no significant
differences among groups, which indicated that the x was
independent of the existence or site of valve incompetence.
x would be expected to decrease in limbs with outflow
obstruction and needs to be tested in such patients. The
findings of our study are thought to coincide with recent
reports,18,19 in terms of air plethysmographic examination,
which have emphasized the significance of increased reflux
rather than ejecting ability of calf muscle pump in deter-
mining the severity of CVI. Criado et al19 also showed that
the venous filling index obtained from air plethysmography
correlated well with the extent of venous reflux examined
with duplex scanning, whereas the ejection fraction did not
separate limbs by type of reflux.
The effectiveness of repeated measurements with the
use of tourniquets to distinguish between superficial, per-
forator, and deep venous disease still remains controver-
sial.6-8 In our study population, separation between SVI
and DVI with the application of ankle cuff was observed in
several hemodynamic parameters. Conceivable fluctuation
with respect to the impact of tourniquets among reports
may arise from the difference in the patient selection or the
site where tourniquets are positioned. Diversity in each
limb as to how the individual venous systems contribute to
overall venous dysfunction may play a more crucial role in
causing the variance among studies. At any rate, the data
obtained from our study suggest that the examination with
the application of tourniquets that are narrow (2.5 cm
wide), which may have a minimal effect on the deep venous
system, offers information to predict the therapeutic bene-
fit of various antireflux procedures on the superficial veins
to some degree.
With respect to correlations of the new parameters with
AVP, I showed a definite correlation with AVP, and no
apparent relationship was seen between x and AVP in our
patients. These results indicated that a determinant of
ambulatory venous hypertension was mainly venous reflux
during exercise and the influence of calf muscle pump was
not prominent in nonobstructive limbs.
In consideration of the changes in venous pressure
accompanied by physiologic movements, several factors
affect these pressure changes: 1, capacity of calf pump to
create the sufficient pressure gradient between deep and
superficial venous system; 2, magnitude of venous reflux in
each venous system, including perforators; 3, property of
vein wall, such as compliance and elasticity; and 4, amount
of arterial inflow. The new parameters described in this
study would mainly assess the previous factors 1 and 2, but
it is possible that they may also reflect factors 3 and 4
hitherto.
A major flaw of our study was that because the presence
of incompetent perforators was not recorded, we could
neither correlate the new parameters with the clinical sever-
ity of disease nor verify the influence of incompetent per-
forators on these parameters. Both of these issues are of
great importance, and further studies including the appli-
cation of duplex scanning to confirm venous abnormalities
in each system should be needed. Another criticism against
this study may arise from the plausible hypothesis of our
theoretic model. Even accepting the rate of pressure reduc-
tion at every tiptoeing as constant, no conclusive evidence
exists that the pressure increase at each step is regular.
However, it can be assumed that the increasing component
is to be constant as well as the decreasing component at
least in the asymptotic state. Moreover, the detailed inter-
pretation of venous pressure changes during exercise ap-
pears to be essential for a better understanding of patho-
physiology in CVI.
We conclude that the mathematic model developed in
this study can separate the two components responsible for
venous pressure changes during tiptoe exercise and provide
new quantitative parameters, which have a potential to
elucidate the complex mechanism in venous system. We
believe that an accurate evaluation of the abnormality in
each component may yield a better understanding of am-
bulatory venous hemodynamics in chronic venous disease
and ultimately lead to better patient care.
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Table, online only. Patient characteristics and immediate and late results of percutaneous coil embolization
Case
Gender/age
(y) Type of procedure
No. of attempts
of UGCR Anticoagulant regimens
Maximal
aneurysm
diameter (mm)
1 F/70 PTCA  stent placement 1 Aspirin  LMWH 28
2 F/70 PTCA 1 Aspirin  warfarin 27
3 F/78 Cardiac catheterization 2 Aspirin 30
4 M/64 Cardiac catheterization – Aspirin  ticlopidin 30
5 M/74 PTCA  stent placement 1 Aspirin  abciximab 22
6 M/52* Cardiac catheterization 1 Aspirin  heparin 17
7 M/65 Cardiac catheterization – Aspirin  LMWH 50
8 F/75 Cardiac catheterization 2 Aspirin  LMWH 30
9 M/79 Cardiac catheterization 2 Aspirin  LMWH
10 F/52 Cardiac catheterization 1  (12 hours) Aspirin 30
11 F/76 Cardiac catheterization – Aspirin  heparin 38
12 M/75 Snare 1 Warfarin 36
13 F/73 PTCA  stent placement – Ticlopidin  LMWH 35
14 M/37 Renal angioplasty 1 Warfarin 32
15 M/77 Cardiac catheterization 1 Aspirin  LMWH 30
16 M/66 PTCA  stent placement 1  (12 hours) Aspirin  warfarin  clopidogrel  LMWH 44
17 M/78 PTCA  stent placemnet 1  (3 hours) Clopidogrel  LMWH  Aspirin 25
PTCA, Percutaneous transluminal coronary angioplasty; LMWH, Low–molecular weight heparin.
*Deceased at 1 year.
Table, online only (Continued).
No. of colls
Additional
compression time
(min)
Immediate
outcome
Doppler
follow-up
(mo)
Clinical
follow-up
(mo) Outcome
2 10 Thrombosis 12.5 20.5 OK
2 – Thrombosis 10.5 18.5 OK
4 15 Thrombosis 17.5 21 OK
3 10 Thrombosis Day 2 18 OK
3 45 Thrombosis Day 1 16 OK
2 3 Thrombosis 1 11 Recurrence at day 30: new
efficient embolization
8 10 Thrombosis 2 8 OK
4 0.5 Thrombosis 1 1 OK
2 1 Thrombosis 11 11 OK
2 4 Thrombosis 6 6 OK
2 – Thrombosis 1 8 OK
9 10 Thrombosis 9 9 OK
6 – Thrombosis 6 6 OK
4 15 Thrombosis Day 7 Day 7 Recurrence at day 7:
surgical treatment
3 5 Thrombosis 2 2 OK
7 12 Thrombosis 1 1 OK
3 5 Thrombosis 3 3 OK
